2027 Medicare Part D Prescription Drug Plans

The following are highlights that will be in place for the 2027 plan year.  

Please note: the actual drug plan options and 2027 benefits will be available for review beginning October 1, 2026.  

• You pay 100% of the drug costs (if applicable) until you reach your annual deductible.
• We expect most plan deductibles to be $700  (up from $615 in 2026), but some plans may have lower or $0 deductibles.  
• Many Part D plans exempt lower-tier medications (like Tier 1 or Tier 2 generics) from the deductible entirely. This results in you only having to meet the deductible on higher tier medications.  
• Insulin covered by Part D and Part B are always excluded from the deductible.  
• Please note: plans with lower deductibles typically have higher monthly premiums and do not guarantee lower out of pocket costs.

• If you have Medicare Part D, you'll pay no cost-sharing (copays or coinsurance) for the remainder of the year on covered Part D drugs when you reach $2,400 in out-of-pocket costs. The cap was $2,100 in 2026.
• In 2027, you'll have the option to pay out-of-pocket costs in monthly installments over the plan yea through the Medicare Prescription Payment Plan (MPPP), instead of when they happen (see section below).

CMS added 15 new medications to the initial pool of 10 drugs from the 2026 cycle.  Notable classes covered include cancers, respiratory, GLP-1s (diabetes/obesity).  Their newly capped Maximum Fair Prices (MFPs) take effect on January 1, 2027. 

• Ozempic; Rybelsus; Wegovy 
• Trelegy Ellipta 
• Xtandi
• Pomalyst
• Ibrance
• Ofev
• Linzess
• Calquence
• Austedo; Austedo XR 
• Breo Ellipta 
• Tradjenta
• Xifaxan
• Vraylar
• Janumet; Janumet XR 
• Otezla

More info available from CMS here

Most drug plans will release their 2027 plan benefits to the public by late September 2026. 

uouY

CMS added 15 new medications to the initial pool of 10 drugs from the 2026 cycle.  Notable classes covered include cancers, respiratory, GLP-1s (diabetes/obesity).  

• Ozempic; Rybelsus; Wegovy 
• Trelegy Ellipta 
• Xtandi
• Pomalyst
• Ibrance
• Ofev
• Linzess
• Calquence
• Austedo; Austedo XR 
• Breo Ellipta 
• Tradjenta
• Xifaxan
• Vraylar
• Janumet; Janumet XR 
• Otezla

 More info a

Here is the full list of all 25 prescription drugs that will have federally capped Maximum Fair Prices (MFPs) starting January 1, 2027. 

Here are the ten drugs for 2026

• Eliquis
• Jardiance
• Xarelto
• Januvia
• Farxiga
• Entresto
• Enbrel
• Imbruvica
• Stelara
• Fiasp; Fiasp FlexTouch; Fiasp PenFill; Novolog FlexPen; Novolog PenFill

The Medicare prescription payment plan was introduced in 2025, and will also be available in 2027.     

• You can spread the out-of-pocket costs for prescription medications into monthly payments over the course of the plan year (the payment plan does not lower your Part D drug costs or save you money).    
• You’ll no longer pay the pharmacy. You will receive a monthly bill from your drug plan and pay the plan directly.  
• You need to enroll in the payment plan by opting in with your plan provider.
• You will also receive a separate bill for your monthly premium if you have one.
• This program may not be a good fit if your Part D drug costs are low and/or consistently the same each month.